Printer Friendly

EDITEK SIGNS EXCLUSIVE, WORLDWIDE DISTRIBUTION AGREEMENT WITH PREVENT, INC.

 BURLINGTON, N.C., July 12 /PRNewswire/ -- EDITEK, Inc. (AMEX: EDI.EC) reported today that it has signed an exclusive, worldwide distribution agreement with PreVent, Inc. for the sale, marketing and distribution of the PreVent breath alcohol product line. PreVent, Inc. is reputed to be North America's largest manufacturer of on-site disposable breath alcohol tests. These tests consists of small tubes containing chemically treated crystals that change color in the presence of alcohol. The person being tested simply blows through the tube and a color change indicates the blood alcohol level.
 EDITEK has been a distributor of the PreVent breath alcohol tests for the past several years. The PreVent breath alcohol tests have been marketed in conjunction with the EDITEK on-site drugs of abuse tests to criminal justice. With the signing of this exclusive distribution agreement, EDITEK will now be responsible for all of the sales, marketing and distribution of the PreVent breath alcohol tests including assumption of the responsibility of the existing PreVent customer base including distributors. The initial term of this agreement is for three years with the opportunity for renewal for three year periods. In addition, EDITEK has the option to assume manufacturing responsibilities for the PreVent breath alcohol tests and/or the option to purchase PreVent, Inc.
 EDITEK will focus its marketing plans to include criminal justice as well as working with existing and possibly new distributors to access other market opportunities including consumer testing domestically and internationally. Current sales levels of the PreVent breath alcohol tests are approximately $500,000. With the continued concern about alcohol consumption, particularly related to drunk driving, the company feels that the market for the PreVent breath alcohol tests will expand dramatically including a significant opportunity for consumer sales whereby individuals can purchase the PreVent breath alcohol test and test themselves prior to taking the wheel of a vehicle.
 EDITEK, Inc. is an emerging, biodiagnostic company with patented technology for the performance of rapid, on-site assays including one-step assays. The company currently sells products for the human/clinical, drugs of abuse and agridiagnostics/food safety testing markets. EDITEK also has research, development and supply agreements with Farnam Companies and the United States Department of Defense for veterinary diagnostics and tests for biological substances respectively.
 -0- 7/12/93
 /CONTACT: Peter Heath, Vice President Finance and Chief Financial Officer, EDITEK, Inc., 919-226-6311/
 (EDI)


CO: EDITEK, Inc.; PreVent, Inc. ST: North Carolina IN: MTC SU:

MM -- CH004 -- 0395 07/12/93 11:52 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 12, 1993
Words:411
Previous Article:MNC FINANCIAL, INC. REPORTS FURTHER IMPROVEMENT IN NONPERFORMING ASSETS AND PROFITABILITY FOR SECOND QUARTER OF 1993
Next Article:/FIRST ADD -- CL002 -- PROVIDENT BANCORP, INC. EARNINGS/
Topics:


Related Articles
DISEASE DETECTION INTERNATIONAL SEEKS INJUNCTION AGAINST EDITEK
PRELIMINARY INJUNCTIONS GRANTED TO PRESERVE STATUS QUO PENDING ARBITRATION OF PATENT LICENSE DISPUTE BETWEEN DISEASE DETECTION INTERNATIONAL AND...
EDITEK, INC. AND RHONE-POULENC DIAGNOSTICS, LTD. ESTABLISH JOINT VENTURE
EDITEK WINS ARBITRATION AGAINST TRANSIA-DIFFCHAMB
EDITEK ANNOUNCES ADVERSE RULING IN DISEASE DETECTION ARBITRATION
EDITEK, INC. ADDS EZ-SCREEN BREATH ALCOHOL TEST TO DRUGS OF ABUSE PRODUCT LINE
EDITEK ANNOUNCES 1995 FISCAL YEAR END RESULTS AND REVIEWS STRATEGIC GROWTH
EDITEK's Board Sets Annual Meeting of Shareholders For November 6, 1996; Adopts Resolution to Increasing Authorized Shares to 60 Million
EDITEK Settles With Preferred Shareholders
EDITEK, Inc. Reports First Quarter Profit in Company's History

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters